The Smart Solution for DNA Removal in Biopharmaceutical Production by Benzonase Endonuclease
Journal of Applied Virology · 2013
DOI: 10.21092/jav.v2i1.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Virology, 2013. Verfasst von Zhu Yang und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
More and more mammalian cells especially continuous cell lines were used to produce vaccines and therapeutic biological products with the rapid development of biomedical technologies. Therefore, more attention should be paid from drug regulatory authorities to the safety of biological products especially quality control of residual DNA and RNA. World Health Organization has evaluated the methods commonly used in vaccine manufacture for their ability to reduce the biological activity of DNA. Benzonase endonuclease is frequently used during the production of vaccines and can degrade all nucleic acid sequences down to oligonucleotides of approximately 3 to 5 base pairs.
Zitieren
APA
Yang, Z., Li, M., Chen, W., & Peters, A. (2013). The Smart Solution for DNA Removal in Biopharmaceutical Production by Benzonase Endonuclease. Journal of Applied Virology. https://doi.org/10.21092/jav.v2i1.26
Vancouver
Yang Z, Li M, Chen W, Peters A. The Smart Solution for DNA Removal in Biopharmaceutical Production by Benzonase Endonuclease. Journal of Applied Virology. 2013. doi:10.21092/jav.v2i1.26
BibTeX
@article{Yang2013,
author = {Yang, Zhu and Li, Mingxin and Chen, Wen and Peters, Alexander},
title = {The Smart Solution for DNA Removal in Biopharmaceutical Production by Benzonase Endonuclease},
journal = {Journal of Applied Virology},
year = {2013},
doi = {10.21092/jav.v2i1.26}
}
EUVIMED